A Randomized, Controlled Clinical Study of Rituximab in Treatment of Primary IgA Nephropathy
Clinical trial NCT05824390 · UNKNOWN
Trial details
- NCT number
- NCT05824390
- Sponsor
- XIEJINGYUAN
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-20
- Primary completion
- 2023-10-01
- Enrollment
- 116
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.